Evidence map›Paper›PMID 38960929›Full record

ArticleClinical and experimental medicine2024

Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation.

Fengbo Xu, Guoqin Wang, Lijun Sun, Hong Cheng

Abstract readCase Reports
In one paragraph

Article in Clinical and experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fengbo XuDepartment of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guoqin WangDepartment of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Lijun SunDepartment of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hong ChengDepartment of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. drchengh@163.com.

Funding

Beijing municipal hospital research and cultivation program project PX2022024capital's fund for health improvement and research 2022-20-2066
6 · The paper itself

Abstract

Warfarin-related nephropathy (WRN) is defined as acute kidney injury subsequent to excessive anticoagulation with warfarin. Patients with mechanical prosthetic valves require long-term anticoagulant therapy. Nonetheless, warfarin remains the sole available option for anticoagulant therapy. Consequently, patients with mechanical prosthetic valves constitute a special group among the entire anticoagulant population. The present study recorded two cases of patients who had undergone mechanical prosthetic valve surgery and were receiving warfarin therapy. They presented to the hospital with gross hematuria and progressive creatinine levels. Notably, their international normalized ratio (INR) did not exceed three. Subsequent renal biopsies confirmed WRN with IgA nephropathy. The two patients continued to receive warfarin as anticoagulation therapy and were prescribed oral corticosteroids and cyclophosphamide, which resulted in improved renal function during the follow-up. Based on a review of all relevant literature and the present study, we proposed a new challenge: must elevated INR levels be one of the criteria for clinical diagnosis of WRN? Perhaps some inspiration can be drawn from the present article.

Indexed as

AnticoagulantsWarfarinAcute Kidney InjuryAdrenal Cortex HormonesAgedBiopsyCyclophosphamideFemaleGlomerulonephritis, IGAHumansInternational Normalized RatioKidneyMaleMiddle AgedAdrenal Cortex HormonesAnticoagulantsCyclophosphamideWarfarinAcute kidney injuryIgA nephropathyInternational normalized ratioWarfarin-related nephropathy

Identifiers

PMID38960929
PMCPMC11222224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.